Literature DB >> 1667651

Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro.

B Watzl1, P Scuderi, R R Watson.   

Abstract

We investigated the in vitro effects of both psychoactive and nonpsychoactive marijuana components on leukocyte secretion of the immunoregulatory cytokines interleukin-1 alpha (IL-1), tumor necrosis factor alpha (TNF), interferon-gamma (IFN) and interleukin-2 (IL-2). Psychoactive delta-9-tetrahydrocannabinol (THC) and nonpsychoactive cannabidiol (CBD) were added to cultures of mitogen-activated human peripheral blood mononuclear cells (PBMC) and the concentrations of IL-1, TNF, IFN and IL-2 in culture supernatants were measured by ELISA systems. Concentrations of THC and CBD, comparable to plasma levels found after smoking marijuana (10-100 ng/ml), increased the concentration of measurable IFN (139 and 68%), while high concentrations of both cannabinoids (5-20 micrograms/ml) completely blocked synthesis and/or release of this cytokine. CBD was also shown to decrease the measurable quantity of both IL-1 and TNF. In contrast to the effects on IFN, IL-1 and TNF, both cannabinoids, had no effect on IL-2 secretion. This report suggests that both psychoactive and nonpsychoactive components of marijuana are immunomodulating and can potentially alter cytokine secretion of human PBMC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667651     DOI: 10.1016/0192-0561(91)90160-9

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  29 in total

1.  Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.

Authors:  S E Straus
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection.

Authors:  Julie C Williams; Sofia Appelberg; Bruce A Goldberger; Thomas W Klein; John W Sleasman; Maureen M Goodenow
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-23       Impact factor: 4.147

Review 3.  Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.

Authors:  Kristina L Leinwand; Mark E Gerich; Edward J Hoffenberg; Colm B Collins
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

Review 4.  Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.

Authors:  Nilson Carlos Ferreira Junior; Maurício Dos-Santos-Pereira; Francisco Silveira Guimarães; Elaine Del Bel
Journal:  Neurotox Res       Date:  2019-10-22       Impact factor: 3.911

5.  Cannabinoid influence on cytokine profile in multiple sclerosis.

Authors:  S Katona; E Kaminski; H Sanders; J Zajicek
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

6.  Dynamic production of tumour necrosis factor-alpha (TNF-alpha) messenger RNA, intracellular and extracellular TNF-alpha by murine macrophages and possible association with protein tyrosine phosphorylation of STAT1 alpha and ERK2 as an early signal.

Authors:  Z M Zheng; S Specter
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

7.  The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

Authors:  A M Malfait; R Gallily; P F Sumariwalla; A S Malik; E Andreakos; R Mechoulam; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

8.  Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw.

Authors:  Barbara Costa; Mariapia Colleoni; Silvia Conti; Daniela Parolaro; Chiara Franke; Anna Elisa Trovato; Gabriella Giagnoni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-12       Impact factor: 3.000

9.  Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.

Authors:  Ewa Kozela; Maciej Pietr; Ana Juknat; Neta Rimmerman; Rivka Levy; Zvi Vogel
Journal:  J Biol Chem       Date:  2009-11-12       Impact factor: 5.157

10.  The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.

Authors:  Erinn S Raborn; Francine Marciano-Cabral; Nancy E Buckley; Billy R Martin; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2007-07-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.